Cimzia
Cimzia is a medicine authorised by Swissmedic under authorisation number 60096. The authorisation holder is UCB-Pharma SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 June 2010 and the authorisation is valid without a time limit. ATC code L04AB05 places the medicine in the group Immunosuppressants.
| Authorisation number | 60096 |
|---|---|
| Name | Cimzia |
| Full name | Cimzia, solution injectable |
| Authorisation holder | UCB-Pharma SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AB05 |
| First authorisation | 11 June 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cimzia, solution injectable | B | 11 June 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | Spritze(n) | L04AB05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Cimzia authorised in Switzerland?
Yes. Cimzia is authorised by Swissmedic under authorisation number 60096, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cimzia have?
Cimzia is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cimzia?
The authorisation holder is UCB-Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.